233P Tumor characteristics of mixed response upon immune checkpoint inhibition (ICI) in advanced melanoma. (December 2022) - Versluis, J.M.; Hoefsmit, E.P.; H. Shehwana,; Dimitriadis, P.; Sanders, J.; Broeks, A.; Blank, C.U.